Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients

This study has been completed.
Sponsor:
Information provided by:
AHS Cancer Control Alberta
ClinicalTrials.gov Identifier:
NCT00351572
First received: July 11, 2006
Last updated: April 15, 2011
Last verified: April 2011

July 11, 2006
April 15, 2011
July 2006
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00351572 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients
Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients

This study will determine whether a new diagnostic test called the Cell Search Assay can detect circulating colon cancer cells in patients who have had surgery for colon cancer and had visible cancer removed. Other parts of the study will look at whether the presence of the circulating tumor cells in blood predicts whether a patient will have their colon cancer return.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

primary care clinic and any other interested parties

Colon Cancer
Procedure: Cell Search Assay
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
30
Not Provided
Not Provided

Inclusion Criteria:

  • stage II or III colon cancer

Exclusion Criteria:

  • none
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00351572
GI-5-0055
Not Provided
Not Provided
AHS Cancer Control Alberta
Not Provided
Principal Investigator: Michael Sawyer, MD AHS Cancer Control Alberta
AHS Cancer Control Alberta
April 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP